抗血小板药物(例如波利维)被用来帮助预防伴心脏病人群中潜在有危险性的血栓形成。
Antiplatelet drugs, such as Plavix, are used to help prevent potentially dangerous blood clots from forming in people with heart disease.
尽管普遍认为抗凝疗法可预防静脉血栓形成，双重抗血小板疗法仍可用来治疗适应性较差的患者。
Although it is presumed that prevention of venous thrombosis is best achieved with anticoagulation, dual antiplatelet therapy can be a substitute for patients with poor compliance.
CD 40 L可能参与血栓形成和血小板活化，急性脑梗死和急性冠状动脉综合征患者血液中的可溶性CD 40 L持续性增高。
CD40L may participate in thrombosis and activation of platelet. The soluble CD40L levels increase persistently in patients with acute cerebral infarction and acute coronary syndrome.
目的 ：研究丹参素胶囊对大鼠血小板聚集性和血液流变学及血栓形成的影响。
Objective: To investigate the effect of Danshensu Capsules on platelet aggregation, experimental thrombosis and hemorheology in rat.
目前，对于接受药物洗脱支架的患者，我们尝试维持双重抗血小板治疗在一年以上，因为我们非常关注晚期支架内血栓形成的可能性。
Right now, we try to keep dual anti-platelet therapy going for up to one year in patients who have a drug-eluting stent because we are very concerned about the possibility of late-stent thrombosis.
凝血系统激活在心腔内血栓形成中的重要性甚于血小板活化，虽然后者也起一定作用。
Activation of blood coagulation is more important in the pathogenesis of intracardiac thrombi than platelet activation, although the latter plays a contributory role.
前言： 目的：探讨补阳还五汤注射液静脉注射对实验性静脉血栓形成前后静脉血中血小板活化因子（PAF）含量的影响。
Objective:To observe the effects of Buyang Huanwu Injection on the platelet activating factor(PAF) of rats with experimental venous thrombus.
目的：探讨糖尿病合并冠心病老年患者支架植入术后三联抗血小板治疗对预防支架内血栓形成和再狭窄的有效性及安全性。
Objective: To investigate the safety and efficacy of triple antiplatelet therapy in aged patients with diabetes mellitus combined with coronary heart disease after percutaneous coronary intervention.
目的：探讨糖尿病合并冠心病老年患者支架植入术后三联抗血小板治疗对预防支架内血栓形成和再狭窄的有效性及安全性。
Objective: To investigate the safety and efficacy of triple antiplatelet therapy in aged patients with diabetes mellitus combined with coronary heart disease after percutaneous coronary intervention.
应用推荐